CCNF: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
 
m (Bot: removing misplaced special no-break space character)
Line 1: Line 1:
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
:''CCNF may also mean [[Canonical conjunctive normal form]] in Boolean algebra.''
{{PBB_Controls
{{Infobox_gene}}
| update_page = yes
'''G2/mitotic-specific cyclin-F''' is a [[protein]] that in humans is encoded by the ''CCNF'' [[gene]].<ref name="pmid7896286">{{cite journal | vauthors = Kraus B, Pohlschmidt M, Leung AL, Germino GG, Snarey A, Schneider MC, Reeders ST, Frischauf AM | title = A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1) | journal = Genomics | volume = 24 | issue = 1 | pages = 27–33 | date = November 1994 | pmid = 7896286 | pmc = | doi = 10.1006/geno.1994.1578 }}</ref><ref name="entrez"/>
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = yes
| update_citations = yes
}}


<!-- The GNF_Protein_box is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
== Function ==
{{GNF_Protein_box
| image =
| image_source =
| PDB =
| Name = Cyclin F
| HGNCid = 1591
| Symbol = CCNF
| AltSymbols =; FBX1; FBXO1
| OMIM = 600227
| ECnumber = 
| Homologene = 1335
| MGIid = 102551
| GeneAtlas_image1 = PBB_GE_CCNF_204826_at_tn.png
| GeneAtlas_image2 = PBB_GE_CCNF_204827_s_at_tn.png
| Function =  
| Component = {{GNF_GO|id=GO:0005634 |text = nucleus}}
| Process = {{GNF_GO|id=GO:0000320 |text = re-entry into mitotic cell cycle}} {{GNF_GO|id=GO:0001890 |text = placenta development}} {{GNF_GO|id=GO:0007049 |text = cell cycle}} {{GNF_GO|id=GO:0007067 |text = mitosis}} {{GNF_GO|id=GO:0051301 |text = cell division}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 899
    | Hs_Ensembl = ENSG00000162063
    | Hs_RefseqProtein = NP_001752
    | Hs_RefseqmRNA = NM_001761
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 16
    | Hs_GenLoc_start = 2419441
    | Hs_GenLoc_end = 2448856
    | Hs_Uniprot = P41002
    | Mm_EntrezGene = 12449
    | Mm_Ensembl = ENSMUSG00000072082
    | Mm_RefseqmRNA = NM_007634
    | Mm_RefseqProtein = NP_031660
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 17
    | Mm_GenLoc_start = 23951498
    | Mm_GenLoc_end = 23977006
    | Mm_Uniprot = Q3TF73
  }}
}}
'''Cyclin F''', also known as '''CCNF''', is a human [[gene]].<ref name="entrez">{{cite web | title = Entrez Gene: CCNF cyclin F| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=899| accessdate = }}</ref>


<!-- The PBB_Summary template is automatically maintained by Protein Box Bot.  See Template:PBB_Controls to Stop updates. -->
This gene encodes a member of the cyclin family. Cyclins are important regulators of cell cycle transitions through their ability to bind and activate cyclin-dependent protein kinases. This member also belongs to the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it was one of the first proteins in which the F-box motif was identified.<ref name="entrez">{{cite web | title = Entrez Gene: CCNF cyclin F| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=899| accessdate = }}</ref>
{{PBB_Summary
| section_title =
| summary_text = This gene encodes a member of the cyclin family. Cyclins are important regulators of cell cycle transitions through their ability to bind and activate cyclin-dependent protein kinases. This member also belongs to the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it was one of the first proteins in which the F-box motif was identified.<ref name="entrez">{{cite web | title = Entrez Gene: CCNF cyclin F| url = http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=899| accessdate = }}</ref>
}}


==References==
== Discovery and gene/protein characteristics ==
{{reflist|2}}
CCNF gene was first discovered in 1994 by Elledge laboratory while experimenting with ''Saccharomyces cerevisiae''.<ref name="Bai_1994">{{cite journal | vauthors = Bai C, Richman R, Elledge SJ | title = Human cyclin F | journal = The EMBO Journal | volume = 13 | issue = 24 | pages = 6087–98 | date = December 1994 | pmid = 7813445 }}</ref> At the same time, the Frischauf laboratory also identified cyclin F as a new cyclin during their search for new candidate genes for polycystic kidney.<ref>{{cite journal | vauthors = Kraus B, Pohlschmidt M, Leung AL, Germino GG, Snarey A, Schneider MC, Reeders ST, Frischauf AM | title = A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1) | journal = Genomics | volume = 24 | issue = 1 | pages = 27–33 | date = November 1994 | pmid = 7896286 | doi = 10.1006/geno.1994.1578 }}</ref> CCNF gene has 17 exons and is located at position 16p13.3 on the human chromosome.<ref name="Bai_1994" /> Its protein, cyclin F, is made up of 786 amino acids and has a predicted molecular weight of 87 kDa.<ref name="Bai_1994" /> Cyclin F is the main member of the [[F-box protein|F-box]] protein family, which has about 40 amino acid motif, forming the F-box.<ref name="Bai_1994" />
==Further reading==
 
Cyclin F resembles most to cyclin A in terms of sequence and expression patterns.<ref name="Bai_1994" /> Moreover, it has additional shared features of cyclins, such as [[PEST sequence|pEST region]], protein quantity, localization, cell cycle-regulated mRNA, and ability to influence [[cell cycle]] and progression.<ref name="Bai_1994" />  Cyclin F differs from other cyclins by its ability to monitor and regulate cell cycle without the need for [[cyclin-dependent kinase]]s (CDKs).<ref name="D'Angiolella_2013">{{cite journal | vauthors = D'Angiolella V, Esencay M, Pagano M | title = A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis | journal = Trends in Cell Biology | volume = 23 | issue = 3 | pages = 135–40 | date = March 2013 | pmid = 23182110 | pmc = 3597434 | doi = 10.1016/j.tcb.2012.10.011 }}</ref> Instead, cyclin F forms part of the [[Ubiquitin proteasome pathway|ubiquitin-proteosome system]] (UPS) and ubiquitinates or directly interacts with the target substrates through the F-box domain.<ref name="D'Angiolella_2013" />
 
== Expression patterns ==
Cyclin F [[Messenger RNA|mRNA]] is expressed in all human tissues, but at different quantities.<ref name="Bai_1994" /> It is found most abundantly in the nucleus, and the quantity levels vary during the different stages of cell cycle.<ref name="Bai_1994" /> Its expression pattern closely resembles the one from [[cyclin A]]. Cyclin F levels begin to rise during S phase and reaches its peak during G2.<ref name="Bai_1994" />
 
== Role in DNA synthesis and repair ==
Cyclin F interacts with other enzymes that are important for DNA synthesis, stability and repair.
 
=== RRM2 ===
[[RRM2]] is a [[ribonucleotide reductase]] (RNR), an enzyme responsible for the conversion of ribonucleotides into dNTPs. dNTPs are essential for DNA synthesis during DNA replication and repair.<ref>{{cite journal | vauthors = Niida H, Katsuno Y, Sengoku M, Shimada M, Yukawa M, Ikura M, Ikura T, Kohno K, Shima H, Suzuki H, Tashiro S, Nakanishi M | title = Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase | journal = Genes & Development | volume = 24 | issue = 4 | pages = 333–8 | date = February 2010 | pmid = 20159953 | pmc = 2816732 | doi = 10.1101/gad.1863810 }}</ref> Cyclin F interacts with RRM2 to control the production of dNTPs in the cell to avoid genomic instability and frequency of mutations.<ref>{{cite journal | vauthors = D'Angiolella V, Donato V, Forrester FM, Jeong YT, Pellacani C, Kudo Y, Saraf A, Florens L, Washburn MP, Pagano M | title = Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair | journal = Cell | volume = 149 | issue = 5 | pages = 1023–34 | date = May 2012 | pmid = 22632967 | pmc = 3616325 | doi = 10.1016/j.cell.2012.03.043 }}</ref>
 
=== CP110 ===
Moreover, cyclin F located at the centrosomes are needed to regulate levels of [[CP110]], a protein involved in centrosome duplication.<ref name="D'Angiolella_2010">{{cite journal | vauthors = D'Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, Dynlacht B, Pagano M | title = SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation | journal = Nature | volume = 466 | issue = 7302 | pages = 138–42 | date = July 2010 | pmid = 20596027 | pmc = 2946399 | doi = 10.1038/nature09140 }}</ref> The regulation of CP110 during G2, through ubiquitin mediated proteolysis, helps to prevent mitotic aberrations.<ref name="D'Angiolella_2010" /> by allowing only one centrosome replication per cell cycle.
 
=== NuSAP ===
NuSAP is a substrate of cyclin F that is involved in cell division.<ref>{{cite journal | vauthors = Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ | title = Global identification of modular cullin-RING ligase substrates | journal = Cell | volume = 147 | issue = 2 | pages = 459–74 | date = October 2011 | pmid = 21963094 | pmc = 3226719 | doi = 10.1016/j.cell.2011.09.019 }}</ref> It is a microtubule-associated protein that is required for the spindle assembly process.<ref name="Ribbeck_2006">{{cite journal | vauthors = Ribbeck K, Groen AC, Santarella R, Bohnsack MT, Raemaekers T, Köcher T, Gentzel M, Görlich D, Wilm M, Carmeliet G, Mitchison TJ, Ellenberg J, Hoenger A, Mattaj IW | title = NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules | journal = Molecular Biology of the Cell | volume = 17 | issue = 6 | pages = 2646–60 | date = June 2006 | pmid = 16571672 | pmc = 1474800 | doi = 10.1091/mbc.E05-12-1178 }}</ref> Its function is to interact with [[microtubule]]s and [[chromatin]] to create stabilization and cross-linking.<ref name="Ribbeck_2006" /> A lack of NuSAP has been linked with an increase in mutations due to impaired chromosome alignment during [[metaphase]], while an excess of NuSAP leads to mitotic arrest and microtubule bundling.<ref>{{cite journal | vauthors = Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg J, Carmeliet G | title = NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization | journal = The Journal of Cell Biology | volume = 162 | issue = 6 | pages = 1017–29 | date = September 2003 | pmid = 12963707 | pmc = 2172854 | doi = 10.1083/jcb.200302129 }}</ref> Cyclin F help to control NUSAP abundance and is therefore essential to proper cell division.
 
Therefore, a defective cyclin F may contribute to hypermutator phenotype and chromosomal instability through RRM2, CP110, and NuSAP pathways.
 
== Clinical significance ==
 
=== Neurodegenerative diseases ===
CCNF mutations have more recently been associated to [[neurodegenerative disease]]s such as [[Frontotemporal dementia]] (FTD), [[Amyotrophic lateral sclerosis]] (ALS), and co-morbid ALS-FTD.<ref name="Williams_2016">{{cite journal | vauthors = Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, Zhang KY, Farrawell N, Vance C, Hu X, Chesi A, Leblond CS, Lee A, Rayner SL, Sundaramoorthy V, Dobson-Stone C, Molloy MP, van Blitterswijk M, Dickson DW, Petersen RC, Graff-Radford NR, Boeve BF, Murray ME, Pottier C, Don E, Winnick C, McCann EP, Hogan A, Daoud H, Levert A, Dion PA, Mitsui J, Ishiura H, Takahashi Y, Goto J, Kost J, Gellera C, Gkazi AS, Miller J, Stockton J, Brooks WS, Boundy K, Polak M, Muñoz-Blanco JL, Esteban-Pérez J, Rábano A, Hardiman O, Morrison KE, Ticozzi N, Silani V, de Belleroche J, Glass JD, Kwok JB, Guillemin GJ, Chung RS, Tsuji S, Brown RH, García-Redondo A, Rademakers R, Landers JE, Gitler AD, Rouleau GA, Cole NJ, Yerbury JJ, Atkin JD, Shaw CE, Nicholson GA, Blair IP | display-authors = 6 | title = CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia | journal = Nature Communications | volume = 7 | pages = 11253 | date = April 2016 | pmid = 27080313 | pmc = 4835537 | doi = 10.1038/ncomms11253 }}</ref><ref>{{cite journal | vauthors = Galper J, Rayner SL, Hogan AL, Fifita JA, Lee A, Chung RS, Blair IP, Yang S | title = Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer | journal = The International Journal of Biochemistry & Cell Biology | volume = 89 | pages = 216–220 | date = August 2017 | pmid = 28652210 | doi = 10.1016/j.biocel.2017.06.011 }}</ref> Whole-genome linkage analysis and genome sequencing identified CCNF to be linked to both familial and sporadic ALS patients.<ref name="Williams_2016" /> ''In vitro'' and ''in vivo'' studies using ALS-linked mutations in CCNF were also carried out. It was found that certain CCNF mutations caused increased ubiquitination of [[TARDBP|TDP-43]] protein in cells, which is a major feature of ALS and FTD pathology.<ref name="Williams_2016" /> In zebrafish, mutant CCNF fish showed motor neuron axonopathy and reduced motor response.<ref>{{cite journal | vauthors = Hogan AL, Don EK, Rayner SL, Lee A, Laird AS, Watchon M, Winnick C, Tarr IS, Morsch M, Fifita JA, Gwee SL, Formella I, Hortle E, Yuan KC, Molloy MP, Williams KL, Nicholson GA, Chung RS, Blair IP, Cole NJ | display-authors = 6 | title = Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype | journal = Human Molecular Genetics | volume = 26 | issue = 14 | pages = 2616–2626 | date = July 2017 | pmid = 28444311 | doi = 10.1093/hmg/ddx136 }}</ref>
 
=== Cancer ===
Cyclin F has a [[Tumor suppressor gene|tumor suppressor]] role because normal expression is involved in cell cycle regulation by inducing G2 arrest and preventing mitosis.<ref>{{cite journal | vauthors = Wang Z, Liu P, Inuzuka H, Wei W | title = Roles of F-box proteins in cancer | journal = Nature Reviews. Cancer | volume = 14 | issue = 4 | pages = 233–47 | date = April 2014 | pmid = 24658274 | pmc = 4306233 | doi = 10.1038/nrc3700 | url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306233/ }}</ref> Moreover, cyclin F through RRM2 and CP110 control centrosome duplication and reduce the frequency of genomic mutations.<ref name="D'Angiolella_2013" /> So far, mutations in CCNF and increased RRM2 expression have been identified in several human cancers.<ref>{{cite journal | vauthors = Zhang K, Hu S, Wu J, Chen L, Lu J, Wang X, Liu X, Zhou B, Yen Y | title = Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis | journal = Molecular Cancer | volume = 8 | pages = 11 | date = February 2009 | pmid = 19250552 | doi = 10.1186/1476-4598-8-11 | url = https://doi.org/10.1186/1476-4598-8-11 }}</ref>
 
== References ==
{{reflist}}
 
== Further reading ==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading
* {{cite journal | vauthors = Nehls M, Lüno K, Schorpp M, Pfeifer D, Krause S, Matysiak-Scholze U, Dierbach H, Boehm T | title = YAC/P1 contigs defining the location of 56 microsatellite markers and several genes across a 3.4-cM interval on mouse chromosome 11 | journal = Mammalian Genome | volume = 6 | issue = 5 | pages = 321–31 | date = May 1995 | pmid = 7626882 | doi = 10.1007/BF00364794 }}
| citations =
* {{cite journal | vauthors = Bai C, Richman R, Elledge SJ | title = Human cyclin F | journal = The EMBO Journal | volume = 13 | issue = 24 | pages = 6087–98 | date = December 1994 | pmid = 7813445 | pmc = 395587 | doi = }}
*{{cite journal | author=Nehls M, Lüno K, Schorpp M, ''et al.'' |title=YAC/P1 contigs defining the location of 56 microsatellite markers and several genes across a 3.4-cM interval on mouse chromosome 11. |journal=Mamm. Genome |volume=6 |issue= 5 |pages= 321-31 |year= 1995 |pmid= 7626882 |doi= }}
* {{cite journal | vauthors = Bai C, Sen P, Hofmann K, Ma L, Goebl M, Harper JW, Elledge SJ | title = SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box | journal = Cell | volume = 86 | issue = 2 | pages = 263–74 | date = July 1996 | pmid = 8706131 | doi = 10.1016/S0092-8674(00)80098-7 }}
*{{cite journal | author=Bai C, Richman R, Elledge SJ |title=Human cyclin F. |journal=EMBO J. |volume=13 |issue= 24 |pages= 6087-98 |year= 1995 |pmid= 7813445 |doi=  }}
* {{cite journal | vauthors = Kong M, Barnes EA, Ollendorff V, Donoghue DJ | title = Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction | journal = The EMBO Journal | volume = 19 | issue = 6 | pages = 1378–88 | date = March 2000 | pmid = 10716937 | pmc = 305678 | doi = 10.1093/emboj/19.6.1378 }}
*{{cite journal  | author=Kraus B, Pohlschmidt M, Leung AL, ''et al.'' |title=A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1). |journal=Genomics |volume=24 |issue= 1 |pages= 27-33 |year= 1995 |pmid= 7896286 |doi= 10.1006/geno.1994.1578 }}
* {{cite journal | vauthors = Fung TK, Siu WY, Yam CH, Lau A, Poon RY | title = Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins | journal = The Journal of Biological Chemistry | volume = 277 | issue = 38 | pages = 35140–9 | date = September 2002 | pmid = 12122006 | doi = 10.1074/jbc.M205503200 }}
*{{cite journal | author=Bai C, Sen P, Hofmann K, ''et al.'' |title=SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. |journal=Cell |volume=86 |issue= 2 |pages= 263-74 |year= 1996 |pmid= 8706131 |doi= }}
* {{cite journal | vauthors = Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, Ishii S, Sugiyama T, Saito K, Isono Y, Irie R, Kushida N, Yoneyama T, Otsuka R, Kanda K, Yokoi T, Kondo H, Wagatsuma M, Murakawa K, Ishida S, Ishibashi T, Takahashi-Fujii A, Tanase T, Nagai K, Kikuchi H, Nakai K, Isogai T, Sugano S | title = Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes | journal = Genome Research | volume = 16 | issue = 1 | pages = 55–65 | date = January 2006 | pmid = 16344560 | pmc = 1356129 | doi = 10.1101/gr.4039406 }}
*{{cite journal | author=Kong M, Barnes EA, Ollendorff V, Donoghue DJ |title=Cyclin F regulates the nuclear localization of cyclin B1 through a cyclin-cyclin interaction. |journal=EMBO J. |volume=19 |issue= 6 |pages= 1378-88 |year= 2000 |pmid= 10716937 |doi= 10.1093/emboj/19.6.1378 }}
*{{cite journal | author=Fung TK, Siu WY, Yam CH, ''et al.'' |title=Cyclin F is degraded during G2-M by mechanisms fundamentally different from other cyclins. |journal=J. Biol. Chem. |volume=277 |issue= 38 |pages= 35140-9 |year= 2002 |pmid= 12122006 |doi= 10.1074/jbc.M205503200 }}
*{{cite journal | author=Strausberg RL, Feingold EA, Grouse LH, ''et al.'' |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899-903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 }}
*{{cite journal  | author=Gerhard DS, Wagner L, Feingold EA, ''et al.'' |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121-7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 }}
*{{cite journal  | author=Kimura K, Wakamatsu A, Suzuki Y, ''et al.'' |title=Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. |journal=Genome Res. |volume=16 |issue= 1 |pages= 55-65 |year= 2006 |pmid= 16344560 |doi= 10.1101/gr.4039406 }}
}}
{{refend}}
{{refend}}


{{gene-16-stub}}
== External links ==
{{WikiDoc Sources}}
* {{UCSC gene info|CCNF}}

Revision as of 04:36, 30 October 2017

CCNF may also mean Canonical conjunctive normal form in Boolean algebra.
VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

G2/mitotic-specific cyclin-F is a protein that in humans is encoded by the CCNF gene.[1][2]

Function

This gene encodes a member of the cyclin family. Cyclins are important regulators of cell cycle transitions through their ability to bind and activate cyclin-dependent protein kinases. This member also belongs to the F-box protein family which is characterized by an approximately 40 amino acid motif, the F-box. The F-box proteins constitute one of the four subunits of the ubiquitin protein ligase complex called SCFs (SKP1-cullin-F-box), which function in phosphorylation-dependent ubiquitination. The F-box proteins are divided into 3 classes: Fbws containing WD-40 domains, Fbls containing leucine-rich repeats, and Fbxs containing either different protein-protein interaction modules or no recognizable motifs. The protein encoded by this gene belongs to the Fbxs class and it was one of the first proteins in which the F-box motif was identified.[2]

Discovery and gene/protein characteristics

CCNF gene was first discovered in 1994 by Elledge laboratory while experimenting with Saccharomyces cerevisiae.[3] At the same time, the Frischauf laboratory also identified cyclin F as a new cyclin during their search for new candidate genes for polycystic kidney.[4] CCNF gene has 17 exons and is located at position 16p13.3 on the human chromosome.[3] Its protein, cyclin F, is made up of 786 amino acids and has a predicted molecular weight of 87 kDa.[3] Cyclin F is the main member of the F-box protein family, which has about 40 amino acid motif, forming the F-box.[3]

Cyclin F resembles most to cyclin A in terms of sequence and expression patterns.[3] Moreover, it has additional shared features of cyclins, such as pEST region, protein quantity, localization, cell cycle-regulated mRNA, and ability to influence cell cycle and progression.[3] Cyclin F differs from other cyclins by its ability to monitor and regulate cell cycle without the need for cyclin-dependent kinases (CDKs).[5] Instead, cyclin F forms part of the ubiquitin-proteosome system (UPS) and ubiquitinates or directly interacts with the target substrates through the F-box domain.[5]

Expression patterns

Cyclin F mRNA is expressed in all human tissues, but at different quantities.[3] It is found most abundantly in the nucleus, and the quantity levels vary during the different stages of cell cycle.[3] Its expression pattern closely resembles the one from cyclin A. Cyclin F levels begin to rise during S phase and reaches its peak during G2.[3]

Role in DNA synthesis and repair

Cyclin F interacts with other enzymes that are important for DNA synthesis, stability and repair.

RRM2

RRM2 is a ribonucleotide reductase (RNR), an enzyme responsible for the conversion of ribonucleotides into dNTPs. dNTPs are essential for DNA synthesis during DNA replication and repair.[6] Cyclin F interacts with RRM2 to control the production of dNTPs in the cell to avoid genomic instability and frequency of mutations.[7]

CP110

Moreover, cyclin F located at the centrosomes are needed to regulate levels of CP110, a protein involved in centrosome duplication.[8] The regulation of CP110 during G2, through ubiquitin mediated proteolysis, helps to prevent mitotic aberrations.[8] by allowing only one centrosome replication per cell cycle.

NuSAP

NuSAP is a substrate of cyclin F that is involved in cell division.[9] It is a microtubule-associated protein that is required for the spindle assembly process.[10] Its function is to interact with microtubules and chromatin to create stabilization and cross-linking.[10] A lack of NuSAP has been linked with an increase in mutations due to impaired chromosome alignment during metaphase, while an excess of NuSAP leads to mitotic arrest and microtubule bundling.[11] Cyclin F help to control NUSAP abundance and is therefore essential to proper cell division.

Therefore, a defective cyclin F may contribute to hypermutator phenotype and chromosomal instability through RRM2, CP110, and NuSAP pathways.

Clinical significance

Neurodegenerative diseases

CCNF mutations have more recently been associated to neurodegenerative diseases such as Frontotemporal dementia (FTD), Amyotrophic lateral sclerosis (ALS), and co-morbid ALS-FTD.[12][13] Whole-genome linkage analysis and genome sequencing identified CCNF to be linked to both familial and sporadic ALS patients.[12] In vitro and in vivo studies using ALS-linked mutations in CCNF were also carried out. It was found that certain CCNF mutations caused increased ubiquitination of TDP-43 protein in cells, which is a major feature of ALS and FTD pathology.[12] In zebrafish, mutant CCNF fish showed motor neuron axonopathy and reduced motor response.[14]

Cancer

Cyclin F has a tumor suppressor role because normal expression is involved in cell cycle regulation by inducing G2 arrest and preventing mitosis.[15] Moreover, cyclin F through RRM2 and CP110 control centrosome duplication and reduce the frequency of genomic mutations.[5] So far, mutations in CCNF and increased RRM2 expression have been identified in several human cancers.[16]

References

  1. ↑ Kraus B, Pohlschmidt M, Leung AL, Germino GG, Snarey A, Schneider MC, Reeders ST, Frischauf AM (November 1994). "A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1)". Genomics. 24 (1): 27–33. doi:10.1006/geno.1994.1578. PMID 7896286.
  2. ↑ 2.0 2.1 "Entrez Gene: CCNF cyclin F".
  3. ↑ 3.0 3.1 3.2 3.3 3.4 3.5 3.6 3.7 3.8 Bai C, Richman R, Elledge SJ (December 1994). "Human cyclin F". The EMBO Journal. 13 (24): 6087–98. PMID 7813445.
  4. ↑ Kraus B, Pohlschmidt M, Leung AL, Germino GG, Snarey A, Schneider MC, Reeders ST, Frischauf AM (November 1994). "A novel cyclin gene (CCNF) in the region of the polycystic kidney disease gene (PKD1)". Genomics. 24 (1): 27–33. doi:10.1006/geno.1994.1578. PMID 7896286.
  5. ↑ 5.0 5.1 5.2 D'Angiolella V, Esencay M, Pagano M (March 2013). "A cyclin without cyclin-dependent kinases: cyclin F controls genome stability through ubiquitin-mediated proteolysis". Trends in Cell Biology. 23 (3): 135–40. doi:10.1016/j.tcb.2012.10.011. PMC 3597434. PMID 23182110.
  6. ↑ Niida H, Katsuno Y, Sengoku M, Shimada M, Yukawa M, Ikura M, Ikura T, Kohno K, Shima H, Suzuki H, Tashiro S, Nakanishi M (February 2010). "Essential role of Tip60-dependent recruitment of ribonucleotide reductase at DNA damage sites in DNA repair during G1 phase". Genes & Development. 24 (4): 333–8. doi:10.1101/gad.1863810. PMC 2816732. PMID 20159953.
  7. ↑ D'Angiolella V, Donato V, Forrester FM, Jeong YT, Pellacani C, Kudo Y, Saraf A, Florens L, Washburn MP, Pagano M (May 2012). "Cyclin F-mediated degradation of ribonucleotide reductase M2 controls genome integrity and DNA repair". Cell. 149 (5): 1023–34. doi:10.1016/j.cell.2012.03.043. PMC 3616325. PMID 22632967.
  8. ↑ 8.0 8.1 D'Angiolella V, Donato V, Vijayakumar S, Saraf A, Florens L, Washburn MP, Dynlacht B, Pagano M (July 2010). "SCF(Cyclin F) controls centrosome homeostasis and mitotic fidelity through CP110 degradation". Nature. 466 (7302): 138–42. doi:10.1038/nature09140. PMC 2946399. PMID 20596027.
  9. ↑ Emanuele MJ, Elia AE, Xu Q, Thoma CR, Izhar L, Leng Y, Guo A, Chen YN, Rush J, Hsu PW, Yen HC, Elledge SJ (October 2011). "Global identification of modular cullin-RING ligase substrates". Cell. 147 (2): 459–74. doi:10.1016/j.cell.2011.09.019. PMC 3226719. PMID 21963094.
  10. ↑ 10.0 10.1 Ribbeck K, Groen AC, Santarella R, Bohnsack MT, Raemaekers T, Köcher T, Gentzel M, Görlich D, Wilm M, Carmeliet G, Mitchison TJ, Ellenberg J, Hoenger A, Mattaj IW (June 2006). "NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules". Molecular Biology of the Cell. 17 (6): 2646–60. doi:10.1091/mbc.E05-12-1178. PMC 1474800. PMID 16571672.
  11. ↑ Raemaekers T, Ribbeck K, Beaudouin J, Annaert W, Van Camp M, Stockmans I, Smets N, Bouillon R, Ellenberg J, Carmeliet G (September 2003). "NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization". The Journal of Cell Biology. 162 (6): 1017–29. doi:10.1083/jcb.200302129. PMC 2172854. PMID 12963707.
  12. ↑ 12.0 12.1 12.2 Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, et al. (April 2016). "CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia". Nature Communications. 7: 11253. doi:10.1038/ncomms11253. PMC 4835537. PMID 27080313.
  13. ↑ Galper J, Rayner SL, Hogan AL, Fifita JA, Lee A, Chung RS, Blair IP, Yang S (August 2017). "Cyclin F: A component of an E3 ubiquitin ligase complex with roles in neurodegeneration and cancer". The International Journal of Biochemistry & Cell Biology. 89: 216–220. doi:10.1016/j.biocel.2017.06.011. PMID 28652210.
  14. ↑ Hogan AL, Don EK, Rayner SL, Lee A, Laird AS, Watchon M, et al. (July 2017). "Expression of ALS/FTD-linked mutant CCNF in zebrafish leads to increased cell death in the spinal cord and an aberrant motor phenotype". Human Molecular Genetics. 26 (14): 2616–2626. doi:10.1093/hmg/ddx136. PMID 28444311.
  15. ↑ Wang Z, Liu P, Inuzuka H, Wei W (April 2014). "Roles of F-box proteins in cancer". Nature Reviews. Cancer. 14 (4): 233–47. doi:10.1038/nrc3700. PMC 4306233. PMID 24658274.
  16. ↑ Zhang K, Hu S, Wu J, Chen L, Lu J, Wang X, Liu X, Zhou B, Yen Y (February 2009). "Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis". Molecular Cancer. 8: 11. doi:10.1186/1476-4598-8-11. PMID 19250552.

Further reading

External links

Retrieved from "https://www.wikidoc.org/index.php?title=CCNF&oldid=1417468"